NCT00584584View on ClinicalTrials.gov

An Exploratory Study of the Effects of a Single Dose of QAX576 (an Interleukin-13 Monoclonal Antibody) on Simulated Hayfever

PHASE2CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

August 31, 2008

Conditions
Allergic Rhinitis
Interventions
DRUG

QAX576

DRUG

Placebo

Trial Locations (2)

Unknown

Novartis Investigator Site, Hanover

Novartis Investigator Site, London

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY